Marvin Schneiderman papers

Collection

Identifier: HMD MS ACC 2009-063

Abstract

UNPROCESSED COLLECTION. Dr. Schneiderman (1918-1997) worked at NCI from 1948-1980, thereafter doing work for private concerns. Collection includes folders on correspondence, critiques and reviews, toxicology, risk assessment, ethical and legal issues, data gathering, agent orange, and cancer.

Dates

Creation: 1922-1996

Extent

3.1 Linear Feet (4 boxes)

Creator

Schneiderman, Marvin A. (Marvin Arthur), 1918- (Person)

Physical Location

Materials stored onsite. History of Medicine Division. National Library of Medicine

Language of Materials

Collection materials primarily in English

Access Restrictions

Unprocessed collection. Access is restricted. See Reference Librarian for information regarding access.

Copyright and Re-use Information

Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.

Privacy Information

Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.

Collection Summary

Dr. Schneiderman (1918-1997) worked at NCI from 1948-1980, thereafter doing work for private concerns. Collection includes folders on correspondence, critiques and reviews, toxicology, risk assessment, ethical and legal issues, data gathering, agent orange, and cancer.